Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chugai Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥11.83T | 30.6x | 2.07 | JP¥7,141 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.4% Upside | Upgrade to Pro+ | |
Daiichi Sankyo | Tokyo | Healthcare | Pharmaceuticals | JP¥8.73T | 0.53 | JP¥4,615 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.6% Upside | Upgrade to Pro+ | ||
Takeda Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥6.77T | 0.46 | JP¥4,263 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.2% Upside | Upgrade to Pro+ | ||
Otsuka Holdings Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥4.91T | 32.7x | -1.88 | JP¥9,128 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.2% Upside | Upgrade to Pro+ | |
Astellas Pharma Inc. | Tokyo | Healthcare | Pharmaceuticals | JP¥3T | 1.25 | JP¥1,670.50 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.9% Upside | Upgrade to Pro+ | ||
Shionogi | Tokyo | Healthcare | Pharmaceuticals | JP¥1.83T | 7.9x | -0.44 | JP¥2,140 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.3% Upside | Upgrade to Pro+ | |
Eisai | Tokyo | Healthcare | Pharmaceuticals | JP¥1.42T | 35.3x | -1.32 | JP¥5,029 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.3% Upside | Upgrade to Pro+ | |
Kyowa Kirin | Tokyo | Healthcare | Pharmaceuticals | JP¥1.31T | 16.5x | 0.36 | JP¥2,570 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.3% Upside | Upgrade to Pro+ | |
Ono Pharmaceutical Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥857.69B | 9.1x | -0.44 | JP¥1,815.50 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5% Upside | Upgrade to Pro+ | |
Rohto Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥628.41B | 23.1x | 3.91 | JP¥2,744.50 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Santen Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥584.11B | 0.06 | JP¥1,688 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.9% Upside | Upgrade to Pro+ | ||
Medipal Holdings Corp | Tokyo | Healthcare | Pharmaceuticals | JP¥513.33B | 11.3x | 0.55 | JP¥2,472.50 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1% Upside | Upgrade to Pro+ | |
Suzuken Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥394.65B | 12x | 0.23 | JP¥5,077 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.4% Upside | Upgrade to Pro+ | |
Tsumura & Co | Tokyo | Healthcare | Pharmaceuticals | JP¥364.25B | 0.17 | JP¥4,800 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.5% Upside | Upgrade to Pro+ | ||
Hisamitsu Pharmaceutical Inc | Tokyo | Healthcare | Pharmaceuticals | JP¥310.53B | 21.7x | 1.86 | JP¥4,220 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.2% Upside | Upgrade to Pro+ | |
Toho Holdings | Tokyo | Healthcare | Pharmaceuticals | JP¥270.45B | 15.8x | 0.2 | JP¥4,312 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.7% Downside | Upgrade to Pro+ | |
Nippon Shinyaku | Tokyo | Healthcare | Pharmaceuticals | JP¥270.15B | 9.9x | 0.58 | JP¥4,013 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.9% Downside | Upgrade to Pro+ | |
Sumitomo Dainippon Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥238.37B | -0.9x | 0.01 | JP¥599 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.3% Downside | Upgrade to Pro+ | |
Sawai Group Holdings Co | Tokyo | Healthcare | Pharmaceuticals | JP¥233.89B | 6.9x | 0.2 | JP¥1,916.50 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.3% Upside | Upgrade to Pro+ | |
Kaken Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥165.68B | 9.1x | 0.47 | JP¥4,380 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -17.7% Downside | Upgrade to Pro+ | |
Kissei Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥156.45B | 15.1x | -1.1 | JP¥3,650 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.3% Upside | Upgrade to Pro+ | |
Towa Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥139.51B | 8.9x | 0.04 | JP¥2,827 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.5% Upside | Upgrade to Pro+ | |
Torii Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥128.43B | 24.5x | 0.43 | JP¥4,580 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -11.4% Downside | Upgrade to Pro+ | |
Mochida Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥118.94B | 26.2x | -1.62 | JP¥3,330 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.6% Downside | Upgrade to Pro+ | |
Nxera Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥104.73B | -27.7x | 12.76 | JP¥1,166 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zeria Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥98.21B | 1.1 | JP¥2,229 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.1% Upside | Upgrade to Pro+ | ||
Kyorin Holdings Inc | Tokyo | Healthcare | Pharmaceuticals | JP¥84.79B | 0.5 | JP¥1,473 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -12.4% Downside | Upgrade to Pro+ | ||
JCR Pharmaceuticals | Tokyo | Healthcare | Pharmaceuticals | JP¥78.33B | -184x | 1.75 | JP¥642 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.7% Upside | Upgrade to Pro+ | |
Katakura Industries | Tokyo | Healthcare | Pharmaceuticals | JP¥63.63B | 22.4x | -2.79 | JP¥1,974 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ASKA Pharmaceutical Holdings Co | Tokyo | Healthcare | Pharmaceuticals | JP¥59.2B | 9.9x | -11.09 | JP¥2,082 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ |